Stefania Meschini Selected Research

Therapeutics

9/2022	Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors.
1/2022	Complementary and Integrative Approaches to Cancer: A Pilot Survey of Attitudes and Habits among Cancer Patients in Italy.
1/2020	The Exploitation of Liposomes in the Inhibition of Autophagy to Defeat Drug Resistance.
10/2019	Anticancer activity of "Trigno M", extract of Prunus spinosa drupes, against in vitro 3D and in vivo colon cancer models.
3/2018	Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy.
4/2014	Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefania Meschini Research Topics

Disease

13	Neoplasms (Cancer) 09/2022 - 05/2003
5	Melanoma (Melanoma, Malignant) 09/2022 - 02/2004
5	Osteosarcoma (Osteogenic Sarcoma) 06/2020 - 11/2008
3	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 10/2019
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2007 - 05/2003
1	Neoplasm Metastasis (Metastasis) 09/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Pain (Aches) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2018
1	Cicatrix (Scar) 09/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Carcinoma (Carcinomatosis) 03/2009
1	Phototoxic Dermatitis (Phototoxicity) 03/2009
1	Lung Neoplasms (Lung Cancer) 05/2008
1	Breast Neoplasms (Breast Cancer) 04/2006
1	Adenocarcinoma 04/2006

Drug/Important Bio-Agent (IBA)

9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2003
6	voacamineIBA 01/2022 - 11/2008
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 05/2003
4	AlkaloidsIBA 06/2020 - 11/2008
2	Fluorouracil (Carac)FDA LinkGeneric 12/2022 - 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	AntioxidantsIBA 11/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2021
1	vobasineIBA 06/2020
1	voacangineIBA 06/2020
1	HydrogelsIBA 01/2020
1	Cytostatic AgentsIBA 01/2020
1	CationsIBA 01/2020
1	CelluloseIBA 01/2020
1	PhytochemicalsIBA 10/2019
1	Liposomes (Liposome)IBA 01/2019
1	LipidsIBA 01/2019
1	SuspensionsIBA 09/2012
1	Troglitazone (Rezulin)FDA Link 01/2012
1	InterferonsIBA 01/2012
1	Interferon Type IIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012
1	AntigensIBA 12/2009
1	early endosome antigen 1IBA 12/2009
1	Singlet OxygenIBA 03/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2009
1	TetrapyrrolesIBA 03/2009
1	Small Interfering RNA (siRNA)IBA 11/2008
1	TubulinIBA 05/2008
1	StilbenesIBA 01/2007
1	combretastatinIBA 01/2007
1	Caspase 3 (Caspase-3)IBA 01/2007
1	AnthracyclinesIBA 04/2006
1	nitroxylIBA 04/2006
1	tempolIBA 04/2006
1	piperidineIBA 04/2006
1	terpinenol-4IBA 02/2004
1	Tea Tree OilIBA 02/2004
1	Proteins (Proteins, Gene)FDA Link 05/2003

Therapy/Procedure

6	Therapeutics 09/2022 - 04/2014
3	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
1	Palliative Care (Palliative Therapy) 09/2022
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2020